Liver angiosarcoma

disease
On this page

Also known as angiosarcoma (disease) of liverangiosarcoma of liverangiosarcoma of the liverhemangiosarcoma of liverhemangiosarcoma of the liverhepatic angiosarcomahepatic hemangiosarcomaLiasliver angiosarcoma (disease)liver hemangiosarcomaprimary angiosarcoma of liverprimary angiosarcoma of the liver

Summary

Liver angiosarcoma (MONDO:0002387) is a disease and 2 clinical trials. A subtype of liver sarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameliver angiosarcoma
Mondo IDMONDO:0002387
DOIDDOID:268
ICD-10-CMC22.3
ICD-11965491615
NCITC4438
SNOMED CT109844006
UMLSC0345907
MedGen138027
GARD0005813
Anatomy (UBERON)UBERON:0002107
Is cancer (heuristic)no

Also known as: angiosarcoma (disease) of liver · angiosarcoma of liver · angiosarcoma of the liver · hemangiosarcoma of liver · hemangiosarcoma of the liver · hepatic angiosarcoma · hepatic hemangiosarcoma · Lias · liver angiosarcoma · liver angiosarcoma (disease) · liver hemangiosarcoma · primary angiosarcoma of liver · primary angiosarcoma of the liver

Data availability: 1 cell line.

Disease family

This is a subtype of liver sarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderdigestive system cancerliver cancerliver sarcomaliver angiosarcoma

Related subtypes (6): liver rhabdomyosarcoma, bile duct sarcoma, liver leiomyosarcoma, liver extraskeletal osteosarcoma, liver fibrosarcoma, undifferentiated (embryonal) sarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified2

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06541652Not specifiedRECRUITINGA French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
NCT03025438Not specifiedCOMPLETEDCytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.